CD4 and neoplasm: Collectively, these results indicate that 130H2 treatment enhances the infiltration of DCs, NK cells, CD4 + T cells, CD8 + T, and M1 macrophages into the tumor microenvironment, effectively reversing its immunosuppressive phenotype.